Gland Pharma on Monday reported a 12 percent year-on-year increase in profit after tax (PAT) to Rs 184 crore for the September quarter, helped by strong performance from CDMO arm Cenexi.The Hyderabad-based drug reported a PAT of Rs 163 crore for the July-September period of the previous fiscal. Operating revenue rose to Rs 1,487 crore […]
